NO20066041L - Anvendelse av substituerte kinolinderivater for behandlingen og legemiddelresistente mykobakterielle sykdommer - Google Patents

Anvendelse av substituerte kinolinderivater for behandlingen og legemiddelresistente mykobakterielle sykdommer

Info

Publication number
NO20066041L
NO20066041L NO20066041A NO20066041A NO20066041L NO 20066041 L NO20066041 L NO 20066041L NO 20066041 A NO20066041 A NO 20066041A NO 20066041 A NO20066041 A NO 20066041A NO 20066041 L NO20066041 L NO 20066041L
Authority
NO
Norway
Prior art keywords
substituted quinoline
drug
treatment
quinoline derivatives
resistant mycobacterial
Prior art date
Application number
NO20066041A
Other languages
English (en)
Other versions
NO338624B1 (no
Inventor
Jozef Frans Elisabetha Gestel
Koenraad Jozef Lodewij Andries
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929150&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20066041(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20066041L publication Critical patent/NO20066041L/no
Publication of NO338624B1 publication Critical patent/NO338624B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Den foreliggende oppfinnelse vedrører anvendelsen av et substituert kinolinderivat for fremstillingen av et medikament for behandlingen av en infeksjon med en legemiddelresistent mykobakteriestamme hvori det substituerte kinolinderivat er en forbindelse ifølge formel (Ia) eller formel (Ib) de farmasøytisk akseptable syre- eller baseaddisjonssalter derav, de stereokjemisk isomere former derav, de tautomere former derav og iV-oksidformene derav. Også krevd er en sammensetning omfattende en farmasøytisk akseptabel bærer og, som aktiv ingrediens, en terapeutisk effektiv mengde av forbindelsene over og ett eller flere andre antimykobakterielle midler.
NO20066041A 2004-05-28 2006-12-28 Anvendelse av substituerte kinolinderivater for behandlingen av legemiddelresistente mykobakterielle sykdommer NO338624B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04102402 2004-05-28
PCT/EP2005/052371 WO2005117875A1 (en) 2004-05-28 2005-05-24 Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases

Publications (2)

Publication Number Publication Date
NO20066041L true NO20066041L (no) 2007-02-27
NO338624B1 NO338624B1 (no) 2016-09-19

Family

ID=34929150

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20066041A NO338624B1 (no) 2004-05-28 2006-12-28 Anvendelse av substituerte kinolinderivater for behandlingen av legemiddelresistente mykobakterielle sykdommer

Country Status (34)

Country Link
US (2) US20070249667A1 (no)
EP (1) EP1753427B1 (no)
JP (2) JP5081617B2 (no)
KR (2) KR20130024969A (no)
CN (2) CN102908347A (no)
AP (1) AP2037A (no)
AR (1) AR049127A1 (no)
AT (1) ATE390925T1 (no)
AU (1) AU2005249231B2 (no)
BR (1) BRPI0510414B1 (no)
CA (1) CA2566544C (no)
CL (1) CL2009001980A1 (no)
CY (1) CY1110388T1 (no)
DE (1) DE602005005810T2 (no)
DK (1) DK1753427T3 (no)
EA (1) EA010651B1 (no)
ES (1) ES2306146T3 (no)
HR (1) HRP20080307T3 (no)
IL (1) IL179630A (no)
JO (1) JO2524B1 (no)
ME (1) ME01105B (no)
MX (1) MXPA06013888A (no)
MY (1) MY140611A (no)
NO (1) NO338624B1 (no)
NZ (1) NZ550840A (no)
PA (1) PA8635201A1 (no)
PL (1) PL1753427T3 (no)
PT (1) PT1753427E (no)
RS (1) RS50585B (no)
SI (1) SI1753427T1 (no)
TW (1) TWI363625B (no)
UA (1) UA90267C2 (no)
WO (1) WO2005117875A1 (no)
ZA (1) ZA200609899B (no)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO340352B1 (no) * 2005-06-08 2017-04-10 Janssen Pharmaceutica Nv Kinolinderivater som antibakterielle midler
NO341283B1 (no) * 2005-06-28 2017-10-02 Janssen Pharmaceutica Nv Kinolinderivater som antibakterielle midler
NO341285B1 (no) * 2005-06-28 2017-10-02 Janssen Pharmaceutica Nv Kinolinderivater som antibakterielle midler
NO342701B1 (no) * 2005-06-28 2018-07-09 Janssen Pharmaceutica Nv Kinolinderivater som antibakterielle midler

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005249231B2 (en) * 2004-05-28 2010-11-11 Janssen Pharmaceutica N.V. Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
BG66437B1 (bg) * 2004-12-24 2014-07-31 Janssen Pharmaceutica N.V. Използване на хинолинови съединения за лечение на латентна туберкулоза
JP5349730B2 (ja) * 2005-06-09 2013-11-20 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗バクテリア剤としてのキノリン誘導体
WO2007022946A1 (de) 2005-08-21 2007-03-01 Abbott Gmbh & Co. Kg Heterocyclische verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
UA97813C2 (uk) 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
JO3271B1 (ar) * 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JO2684B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO2685B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO2725B1 (en) * 2006-12-06 2013-09-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2970B1 (en) * 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
MD4009C2 (ro) * 2008-07-15 2010-08-31 Институт Химии Академии Наук Молдовы Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
RU2404971C2 (ru) * 2008-12-02 2010-11-27 ЗАО "Фарм-Синтез" Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе
WO2011031926A1 (en) * 2009-09-11 2011-03-17 Vertex Pharmaceuticals Incorporated Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-n-[3-(4-pyridyl)-1-[2-[4-pyridyl)ethyl]propanamide and uses thereof
CN102249935B (zh) 2010-05-17 2015-05-20 中国人民解放军军事医学科学院毒物药物研究所 芳香2-丁醇类化合物及其医药用途
CA2869453C (en) 2012-04-27 2021-03-02 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
KR102110355B1 (ko) 2012-04-27 2020-05-14 얀센 파마슈티카 엔.브이. 항균성 퀴놀린 유도체
CN105330595B (zh) * 2014-07-14 2019-12-10 上海嘉坦医药科技有限公司 吡啶衍生物及其作为抗分支杆菌的应用
JP6362235B2 (ja) * 2014-07-14 2018-07-25 ツーセン ファーマシューティカル カンパニー リミテッド ピリジン誘導体およびその抗マイコバクテリウムにおける使用
LT3250182T (lt) 2015-01-27 2023-07-10 Janssen Pharmaceutica Nv Dispersinės kompozicijos
CN106279017A (zh) * 2015-05-21 2017-01-04 重庆圣华曦药业股份有限公司 贝达喹啉晶型、组合物及其制备方法
KR102106318B1 (ko) * 2015-10-20 2020-05-06 쯔지앙 하이썬 파머슈티컬 컴퍼니, 리미티드 베다퀼린 푸마레이트의 결정형 및 그의 제조방법
CN108473428B (zh) * 2016-01-13 2021-07-23 上海嘉坦医药科技有限公司 一种吡啶衍生物类化合物的制备方法及其中间体和晶型
ES2934785T3 (es) * 2016-03-07 2023-02-27 Global Alliance For Tb Drug Development Inc Compuestos antibacterianos y usos de los mismos
CN107243008B (zh) * 2017-04-13 2021-03-30 中国科学院广州生物医药与健康研究院 吡唑并[1,5-a]吡啶类化合物的新应用及一种治疗脓肿分枝杆菌感染的组合物
WO2019044941A1 (ja) * 2017-09-01 2019-03-07 学校法人北里研究所 マイコバクテリウム・アビウム複合感染症に対する治療活性を有する新規化合物及びその製造方法
WO2020047596A1 (en) * 2018-09-04 2020-03-12 Monash University Antibacterial compounds and methods of use
WO2020144197A1 (en) 2019-01-09 2020-07-16 Janssen Pharmaceutica Nv Combination in the treatment of nontuberculous mycobacterial diseases
CA3163103A1 (en) * 2019-11-26 2021-06-03 Nanyang Technological University Compounds for treating tuberculosis
CN110804016B (zh) * 2019-12-05 2022-11-04 福建省微生物研究所 抗结核分枝杆菌的二芳基喹啉衍生物
CN116406270A (zh) 2020-11-12 2023-07-07 詹森药业有限公司 在治疗非结核分枝杆菌疾病时的贝达喹啉、乙胺丁醇和大环内酯的组合
CN117050006B (zh) * 2022-05-13 2026-02-13 广州嘉越医药科技有限公司 一种吡啶衍生物、中间体、制备方法和应用
WO2023227123A1 (zh) * 2022-05-27 2023-11-30 广州嘉越医药科技有限公司 吡啶衍生物的用途
WO2023232838A1 (en) 2022-05-31 2023-12-07 Janssen Pharmaceutica Nv Bedaquiline for use in the treatment of leprosy
US20240199608A1 (en) * 2022-11-15 2024-06-20 Eli Lilly And Company Ahr agonists
WO2025068448A1 (en) 2023-09-28 2025-04-03 Janssen Pharmaceutica Nv Atp synthase inhibitors for use in the treatment of non-tuberculosis mycobacteria

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399558A (en) * 1993-11-24 1995-03-21 Pathogenesis Corporation Isoflavonoid antibacterial compounds, compositions and use
US5965572A (en) * 1996-10-28 1999-10-12 The United States Of America As Respresented By The Secretary Of The Army Methods for treating antibiotic-resistant infections
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
DK1527050T3 (da) * 2002-07-25 2010-07-19 Janssen Pharmaceutica Nv Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer
AU2005249231B2 (en) * 2004-05-28 2010-11-11 Janssen Pharmaceutica N.V. Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
CA2528849C (en) * 2005-06-08 2014-01-14 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO340352B1 (no) * 2005-06-08 2017-04-10 Janssen Pharmaceutica Nv Kinolinderivater som antibakterielle midler
NO341283B1 (no) * 2005-06-28 2017-10-02 Janssen Pharmaceutica Nv Kinolinderivater som antibakterielle midler
NO341285B1 (no) * 2005-06-28 2017-10-02 Janssen Pharmaceutica Nv Kinolinderivater som antibakterielle midler
NO342701B1 (no) * 2005-06-28 2018-07-09 Janssen Pharmaceutica Nv Kinolinderivater som antibakterielle midler

Also Published As

Publication number Publication date
SI1753427T1 (sl) 2008-10-31
EP1753427A1 (en) 2007-02-21
UA90267C2 (ru) 2010-04-26
BRPI0510414B1 (pt) 2022-04-05
US20100168133A1 (en) 2010-07-01
PT1753427E (pt) 2008-07-04
IL179630A (en) 2011-05-31
CN1976704A (zh) 2007-06-06
MXPA06013888A (es) 2007-01-26
JP2012229239A (ja) 2012-11-22
US20070249667A1 (en) 2007-10-25
ATE390925T1 (de) 2008-04-15
TWI363625B (en) 2012-05-11
RS50585B (sr) 2010-05-07
CY1110388T1 (el) 2015-04-29
CA2566544C (en) 2012-04-17
EP1753427B1 (en) 2008-04-02
ZA200609899B (en) 2009-01-28
JO2524B1 (en) 2010-03-17
NO338624B1 (no) 2016-09-19
CN102908347A (zh) 2013-02-06
AU2005249231B2 (en) 2010-11-11
PL1753427T3 (pl) 2008-09-30
DE602005005810D1 (de) 2008-05-15
ME01105B (me) 2013-03-20
EA200602260A1 (ru) 2007-04-27
PA8635201A1 (es) 2006-05-16
AP2006003828A0 (en) 2006-12-31
CL2009001980A1 (es) 2010-04-16
EA010651B1 (ru) 2008-10-30
HK1106136A1 (en) 2008-03-07
KR20130024969A (ko) 2013-03-08
ES2306146T3 (es) 2008-11-01
MY140611A (en) 2009-12-31
JP5675718B2 (ja) 2015-02-25
CA2566544A1 (en) 2005-12-15
KR101371653B1 (ko) 2014-03-07
DK1753427T3 (da) 2008-07-21
AU2005249231A1 (en) 2005-12-15
AP2037A (en) 2009-10-09
CN1976704B (zh) 2012-12-05
AR049127A1 (es) 2006-06-28
HRP20080307T3 (hr) 2008-07-31
JP5081617B2 (ja) 2012-11-28
IL179630A0 (en) 2007-07-04
BRPI0510414A (pt) 2007-10-23
DE602005005810T2 (de) 2009-04-09
KR20070017393A (ko) 2007-02-09
WO2005117875A1 (en) 2005-12-15
JP2008500992A (ja) 2008-01-17
NZ550840A (en) 2010-01-29
TW200608974A (en) 2006-03-16

Similar Documents

Publication Publication Date Title
NO20066041L (no) Anvendelse av substituerte kinolinderivater for behandlingen og legemiddelresistente mykobakterielle sykdommer
EA200970535A1 (ru) Антибактериальные производные хинолина
BR0317572A (pt) Benzoxazinas e seus derivados como inibidores de pi3ks
MX2011012627A (es) Derivados aminobutiricos sustituidos como inhibidores de nepralisina.
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
EA200970534A1 (ru) Антибактериальные производные хинолина
NO20081008L (no) Antibakterielle kinolinderivater
SE0002476D0 (sv) New compounds
NO20092547L (no) Antibakterielle kinolin-derivater
NO20092536L (no) Antibakterielle kinolin-derivater
NO20092540L (no) Antibakterielle kinolin-derivater
ATE473212T1 (de) Hiv-inhibierende 2-(4-cyanophenyl)-6- hydroxylaminopyrimidine
NO20092541L (no) Antibakterielle kinolin-derivater
BRPI0606501A2 (pt) derivados de ácido 3-fenilpropiÈnico, composto, composição farmacêutica que o contém, utilização do composto e método de tratamento e/ou profilaxia de enfermidades e condições mediadas por gama receptor ativado por proliferador de peroxissome (ppary)
NO20064298L (no) Piperazinureaderivater til behandling av endometriose
GEAP202516640A (en) Crystal form of a pde4 inhibitor
TN2011000593A1 (en) Substituted aminobutyric derivatives as neprilysin inhibitors